MacuMira — A New Advanced Option for Dry AMD in Australia
Age-related macular degeneration (AMD) is a progressive eye condition and one of the leading causes of vision loss in adults over 50. Until now, most treatments have focused on the later, “wet” form of AMD. But a promising new therapy is emerging for early and intermediate dry AMD.
What Is MacuMira?
MacuMira is a non-invasive, microcurrent-based treatment designed to support retinal cell function and macular health in dry AMD.
Unlike conventional approaches that often slow progression, MacuMira aims to restore function by stimulating cells in the retina. It is used as part of a comprehensive AMD management plan, alongside diet, lifestyle, and visual support strategies.
How MacuMira Works
The treatment uses a gentle, targeted microcurrent applied to the eye area to stimulate the retinal pigment epithelium (RPE) cells.
This stimulation enhances mitochondrial activity in retinal cells, boosting ATP (energy) production, which helps cellular “cleanup” of by-products like drusen and lipofuscin.
Because it is non-invasive, there are no injections, no surgery, and no drugs involved.
The treatment consists of:
- Loading phase: Four sessions of 32 minutes over ~10 days
- Maintenance phase: One session every three months thereafter
What to Expect During a Session
Comfort: You’ll sit comfortably, and a disposable cap will be applied for hygiene.
Electrode placement: Pads are placed on either side of the head.
Treatment: A gentle microcurrent is delivered over closed eyes, stimulating blood flow and cellular repair in the retina.
Patients may feel mild pressure around the area, but the experience is generally painless.
The session takes ~32 minutes
Many report noticing visual improvement within a week, continued through maintenance sessions.
Aftercare: Electrodes are removed; there is no downtime you can resume normal activities immediately.
Follow-ups: After the initial loading phase, treatment is repeated quarterly to sustain results.
Who Might Be Suited for MacuMira?
MacuMira may be appropriate if you:
Have been diagnosed with dry AMD
Want a non-invasive option to help preserve vision
Are seeking a holistic, long-term approach including nutrition, supplements, and visual aids
At an initial consultation, your eye health, AMD progression, medical history, and previous treatments will be reviewed to assess whether MacuMira is a good fit for you.
Why Consider MacuMira?
Adding MacuMira to your AMD management plan may help:
Preserve and enhance visual function
Strengthen retinal cell health
Slow the progression of degenerative changes
Support a comprehensive, patient-centric approach to vision care
If you or a loved one has dry AMD, a tailored consultation can help determine whether this advanced treatment is appropriate.
Contact us today to book a MacuMira assessment and explore how this therapy might fit within your eye health strategy.
Frequently Asked Questions
How does MacuMira help with vision loss from dry AMD?
MacuMira delivers gentle microcurrent energy through your eyelids that stimulates the retina. This is designed to help support your visual function and slow the progression of dry AMD.
What is a MacuMira treatment session like?
Treatments take place at your MacuMira provider’s eye care office, with each session lasting about 32 minutes. During the treatment, you will be seated or reclined while a headset is placed over your eyes. Contoured eye cups rest gently on your closed eyelids, delivering microcurrent stimulation to the retina. Many patients find it relaxing enough to fall asleep during treatment. Some patients experience a mild tingling sensation or brief patterns of light (called phosphenes), which are a normal response to the stimulation. After the session, you can continue with your day as normal with no downtime or restrictions.
Is MacuMira painful or invasive?
No. MacuMira treatment isn’t painful, and there are no needles or drugs involved. It’s completely noninvasive. Some patients feel a slight tingling sensation during the session, but it’s generally very comfortable and well-tolerated.
When will I notice results from MacuMira dry AMD treatment?
Most patients report vision improvements within the first 10 days of treatment. Results vary, but many dry AMD patients describe better contrast (ability to see detail in dim light), sharper reading vision, or less glare sensitivity after that initial 10-day phase.
Is MacuMira a cure for dry AMD?
Unfortunately, there is currently no cure for dry AMD. MacuMira is not a cure. However, it may help improve functional vision and slow progressive vision loss in people with dry AMD.
How long do the benefits of dry AMD treatment last?
Many patients who receive MacuMira begin to notice improvements within the first 10 days (initial “loading” phase). To maintain those gains, follow-up treatments are typically recommended at least every 3 months. Your eye care provider will determine the ideal schedule based on your condition and how your vision responds.
Can I still use my AREDS vitamins and glasses if I have MacuMira treatment?
Yes. MacuMira can be used alongside your current vision aids and AREDS or AREDS2 supplements. It doesn’t interfere with any other aspects of your eye care.
Is MacuMira safe?
Yes. MacuMira is a noninvasive treatment that has demonstrated a clinically proven strong safety profile. It has undergone rigorous safety review and licensing by Health Canada and has been TGA approved in Australia. The stimulation uses microcurrent levels that are incapable of causing muscle contraction and remain well below thresholds associated with discomfort or tissue damage. No adverse events were reported in the prospective clinical study, and the treatment has now been used in clinical settings with excellent tolerability across thousands of treatment sessions. Patients typically find the treatment comfortable and easy to complete. It doesn’t involve pills, lasers, injections, or any surgery.
What other dry AMD treatments are available?
After diagnosing early stage dry AMD, eye care providers typically recommend lifestyle changes such as healthy eating, quitting smoking, and regular exercise to potentially slow the progression of dry AMD. For intermediate dry AMD, eye care providers typically recommend dietary supplements, such as AREDS or AREDS2 vitamins. These may slow the progression of the disease, but do not improve vision.
Please note that this information is general, and not medical advice.
The information on this page has been adapted from MacuMira. More information can be found at https://anz.macumira.com/dry-amd-treatment .